In 2020, three Officer positions will be vacated and 7 of the 12 Councilors-at-large representing the Regions will be changing. The elections will take place early in 2020 and those elected will assume their new roles starting at the 2020 TTS Congress in Seoul.
Members can access the online nominating form at www.tts.org/nominations. Since each nominee must have his or her form signed by three supporting members (including him/herself), the online process allows for efficient and rapid circulation.
For more information on elections, visit the TTS website and consult the By-Laws in the “About” section.
February 21-23, 2020 - Dublin, Ireland - Kidney Disease: Improving Global Outcomes (KDIGO) is an international organization whose mission is to improve the care and outcomes of kidney disease patients worldwide by promoting coordination, collaboration, and integration of initiatives to develop and implement clinical practice guidelines. Periodically, KDIGO hosts conferences on topics of importance to patients with kidney disease. These conferences are designed to review the state of the art on a focused subject and to ask conference participants to determine what needs to be done in this area to improve patient care and outcomes. Sometimes the recommendations from these conferences lead to KDIGO guideline efforts and other times they highlight areas for which additional research is needed to produce evidence that may lead to guidelines in the future. This current Controversies Conference sponsored by KDIGO is the fourth in our cardiovascular series and relates to Central and Peripheral Arterial Diseases in Chronic Kidney Disease. The preceding conferences addressed arrhythmias, heart failure, and coronary and valvular heart disease in the setting of CKD.
The TTS-ILTS Paired Transplant Centers Program is a collaboration between The Transplantation Society (TTS) and the International Liver Transplantation Society (ILTS) supporting new liver transplant programs in emerging countries.
Articulate the ethical questions in VCA, Describe the differences in the ethical challenges between VCA and Solid Organ Transplants and enumerate possible solutions.
This month you will find a bumper issue for lung transplanters with 6 clinical papers covering multiple important topics. The search for genetic biomarkers remains as intense and as difficult to realize as ever. Bilirubin to improve Islets - is that too easy? Oligonucleotides to improve DCD hearts? In the field of liver transplantation the predictors of outcome are everywhere you look, but how many of them are useful and what can you do about them anyway? Some great answers are provided. Renal histology continues its rich vein of discovery helping predict and manage posttransplant outcomes. Plenty of reading for quiet December nights.
The December 2019 issue of Transplantation Direct is now available in open-access. First, we would like to highlight articles on the topic of liver transplantation, covering aspects such as using the “kidney donor profile index" to estimate liver transplant outcomes (USA), and using early posttransplant lactate/pyruvate ratios to predict ischemic-reperfusion complications (Sweden). From an ethical - tutorial perspective, there are interesting articles on developing patient-centered intervention in cases of alcoholic liver disease based on the study of patient experiences (USA), and another group reports on cases illustrating the complicated situation of public solicitation for living liver donation where it involves the (Canadian) news media. In kidney transplantation, there is an article on results from a large series (Spain) of patients using direct-acting antivirals for hepatitis C treatment, and a Swiss group reports on a randomized controlled trial comparing behavioral versus educational weight management methods in transplant recipients. A group from the Netherlands performed a study on detecting donor-derived posttransplant malignancies in their organ transplant recipients and provides rationale for suggesting peri-transplant screening by whole body CT imaging. We welcome everyone to visit our Transplantation Direct website for full article details.
Nov. 29 - Scientists are experimenting with ways to selectively target the body’s blood-making cells for destruction. Early studies in animals and people suggest that the approach could make blood stem-cell transplants — powerful but dangerous procedures that are used mainly to treat blood cancers — safer, and thereby broaden their use. The studies come as evidence piles up that such transplants can also treat some autoimmune disorders and genetic diseases.
Dec. 2 - The addition of plerixafor to granulocyte colony-stimulating factor (G-CSF) treatment after autologous stem cell transplantation may not enhance lymphocyte recovery in patients with multiple myeloma (MM), according to study results published in the American Journal of Hematology.
Nov. 27 - Elmi Muller discusses the long-term outcomes of HIV-positive patients who received kidneys from deceased HIV-positive donors. Her study found that the survival rates of patients were high and there was no resistance to drug regimens passed on through the donor kidney.
Nov. 27 - Biologists have uncovered the mechanism by which stem-cell therapies improve heart function. Working in mice, a team of researchers found that the cells prompt an immune response that improves the organ’s function and also discovered how to mimic this repair with a chemical.
Dec. 2 - Over the last 30 years, the concept of 3D priting has developed toward new horizons, leading to the production of 3D artificial bio tissues that resemble the architecture and function of native ones. In this case, when used to deposit living cells layer-by-layer, we talk more specifically about 3D bioprinting.